Výsledky vyhľadávania - "Cognitive Dysfunction/metabolism"

  1. 1
  2. 2
  3. 3

    Zdroj: Alzheimers Dement
    Madsen, L S, Ismail, R, Parbo, P, Kjeldsen, P L, Schaldemose, J L, Hansen, K V, Gottrup, H, Aanerud, J, Eskildsen, S F & Brooks, D J 2024, 'Microglial responses partially mediate the effect of Aβ on cognition in Alzheimer's disease', Alzheimer's & Dementia, vol. 20, no. 11, pp. 8028-8037. https://doi.org/10.1002/alz.14298

    Popis súboru: application/pdf

  4. 4
  5. 5
  6. 6

    Zdroj: Mol Psychiatry
    Molecular psychiatry, vol. 29, no. 11, pp. 3669-3679
    Camporesi, Sara; Xin, Lijing; Golay, Philippe; Eap, Chin Bin; Cleusix, Martine; Cuenod, Michel; Fournier, Margot; Hashimoto, Kenji; Jenni, Raoul; Ramain, Julie; Restellini, Romeo; Solida, Alessandra; Conus, Philippe; Do, Kim Q; Khadimallah, Ines (2024). Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study. (In Press). Molecular psychiatry Springer Nature 10.1038/s41380-024-02631-4 <http://dx.doi.org/10.1038/s41380-024-02631-4>
    Camporesi, Sara; Xin, Lijing; Golay, Philippe; Eap, Chin Bin; Cleusix, Martine; Cuenod, Michel; Fournier, Margot; Hashimoto, Kenji; Jenni, Raoul; Ramain, Julie; Restellini, Romeo; Solida, Alessandra; Conus, Philippe; Do, Kim Q; Khadimallah, Ines (2024). Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study. Molecular psychiatry, 29(11), pp. 3669-3679. Springer Nature 10.1038/s41380-024-02631-4 <http://dx.doi.org/10.1038/s41380-024-02631-4>

    Popis súboru: application/pdf

  7. 7
  8. 8

    Zdroj: Alzheimers Dement
    Alzheimer's & dementia, vol. 21, no. 4, pp. e70126

    Popis súboru: application/pdf

  9. 9
  10. 10
  11. 11

    Zdroj: Alzheimers Res Ther
    Alzheimer’s Research & Therapy, Vol 17, Iss 1, Pp 1-11 (2025)
    Alzheimer's research & therapy, vol. 17, no. 1, pp. 46
    ALZHEIMERS RESEARCH & THERAPY, 17 (1)

    Popis súboru: application/pdf; application/application/pdf

  12. 12
  13. 13

    Zdroj: Eur J Nucl Med Mol Imaging
    European journal of nuclear medicine and molecular imaging 51(4), 1035-1049 (2024). doi:10.1007/s00259-023-06530-8
    European Journal of Nuclear Medicine and Molecular Imaging, vol 51, iss 4

    Predmety: Florbetapir-PET, Aging, Apolipoprotein E4, Clinical sciences, genetics [Alzheimer Disease], Neurodegenerative, Alzheimer's Disease, metabolism [Cognitive Dysfunction], 2.1 Biological and endogenous factors, genetics [Apolipoprotein E4], Aniline Compounds, Original Article, Myelin, Tau, APOE, Medical and Health Sciences, Brain, 16. Peace & justice, ddc, Other Physical Sciences, Nuclear Medicine & Medical Imaging, Neurological, Cognitive Dysfunction/metabolism [MeSH], Demyelinating Diseases/metabolism [MeSH], Amyloid beta-Peptides/metabolism [MeSH], Humans [MeSH], Aniline Compounds [MeSH], Alzheimer Disease/diagnostic imaging [MeSH], Brain/metabolism [MeSH], Ethylene Glycols [MeSH], Apolipoproteins E [MeSH], Positron-Emission Tomography [MeSH], Alzheimer Disease/genetics [MeSH], Apolipoprotein E4/genetics [MeSH], Alzheimer Disease/metabolism [MeSH], tau Proteins/metabolism [MeSH], Biomedical Imaging, metabolism [Demyelinating Diseases], florbetapir, Ethylene Glycols, metabolism [Alzheimer Disease], Clinical Sciences, metabolism [Amyloid beta-Peptides], tau Proteins, Apolipoproteins E, Clinical Research, Alzheimer Disease, Acquired Cognitive Impairment, Humans, Cognitive Dysfunction, ddc:610, Amyloid beta-Peptides, Biomedical and Clinical Sciences, Neurosciences, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Alzheimer's Disease Neuroimaging Initiative, metabolism [tau Proteins], Brain Disorders, 4.1 Discovery and preclinical testing of markers and technologies, metabolism [Brain], Positron-Emission Tomography, Dementia, diagnostic imaging [Alzheimer Disease], Demyelinating Diseases

    Popis súboru: application/pdf

  14. 14

    Zdroj: Aging Clinical and Experimental Research, 37 (1), 5 (2025)

  15. 15
  16. 16
  17. 17

    Zdroj: Mol Neurodegener
    Molecular Neurodegeneration, Vol 19, Iss 1, Pp 1-25 (2024)
    Molecular neurodegeneration 19(1), 64 (2024). doi:10.1186/s13024-024-00752-6

    Popis súboru: application/pdf; text/xml

  18. 18

    Zdroj: Mol Psychiatry
    Molecular Psychiatry, 29 (6)
    Molecular Psychiatry

    Popis súboru: application/pdf; application/application/pdf

  19. 19

    Zdroj: Mol Psychiatry
    Leng, F, Hinz, R, Gentleman, S, Hampshire, A, Dani, M, Brooks, D J & Edison, P 2023, 'Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease', Molecular Psychiatry, vol. 28, no. 3, pp. 1303-1311. https://doi.org/10.1038/s41380-022-01878-z
    Leng, F, Hinz, R, Gentleman, S, Hampshire, A, Dani, M, Brooks, D J & Edison, P 2022, 'Neuroinflammation is independently associated with brain network dysfunction in Alzheimer’s disease', Molecular psychiatry. https://doi.org/10.1038/s41380-022-01878-z

    Popis súboru: application/pdf

  20. 20

    Prispievatelia: Quenon, Lisa Collij, Lyduine E den Braber, Anouk a ďalší

    Zdroj: Alzheimers Res Ther
    Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-13 (2024)
    the AMYPAD Consortium 2024, 'Amyloid-PET imaging predicts functional decline in clinically normal individuals', Alzheimer's Research and Therapy, vol. 16, no. 1, 130. https://doi.org/10.1186/s13195-024-01494-9
    Alzheimer's research & therapy 16(1), 130 (2024). doi:10.1186/s13195-024-01494-9
    Alzheimer's research & therapy, Vol. 16, no. 1, p. 130 [1-13] (2024)

    Popis súboru: application/pdf